Register for our free email digests:
Division of Amgen Inc.
Latest From MedImmune LLC
An undisclosed G-protein coupled receptor playing a role in inflammatory disease will be the focus of a drug pact between Heptares and PeptiDream.
Sponsors have been increasingly developing vaccine candidates for the respiratory syncytial virus with an unmet need existing for infants; the advisory committee will evaluate FDA's proposed approach for developing candidates in the target population.
Bahija Jallal, vice president of AstraZeneca and head of MedImmune, told a packed room of mostly female health care employees that in her career she has "followed her heart and the science" to reach goals she had not imagined possible, as she accepted the Healthcare Businesswomen's Association's 2017 Woman of the Year award.
In another vote of confidence in one of its newer respiratory assets, AstraZeneca is extending to Asia its already broad rights to benralizumab, adding to a deal it already has with Kyowa Hakko Kirin for Japan.
You must sign in to use this functionality
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.